|
1
|
Ma H, Shu Y, Pan S, Chen J, Dai J, Jin G,
Hu Z and Shen H: Polymorphisms of key chemokine genes and survival
of non-small cell lung cancer in Chinese. Lung Cancer. 74:164–169.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Devarakonda S, Morgensztern D and Govindan
R: Genomic alterations in lung adenocarcinoma. Lancet Oncol.
16:e342–e351. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Bruin EC, McGranahan N, Mitter R, Salm
M, Wedge DC, Yates L, Jamal-Hanjani M, Shafi S, Murugaesu N, Rowan
AJ, et al: Spatial and temporal diversity in genomic instability
processes defines lung cancer evolution. Science. 346:251–256.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang J, Fujimoto J, Zhang J, Wedge DC,
Song X, Zhang J, Seth S, Chow CW, Cao Y, Gumbs C, et al: Intratumor
heterogeneity in localized lung adenocarcinomas delineated by
multiregion sequencing. Science. 346:256–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Håkansson L and Tropé C: On the presence
within tumours of clones that differ in sensitivity to cytostatic
drugs. Acta Pathol Microbiol Scand A. 82:35–40. 1974.PubMed/NCBI
|
|
7
|
Nowell PC: The clonal evolution of tumor
cell populations. Science. 194:23–28. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fidler IJ and Kripke ML: Metastasis
results from preexisting variant cells within a malignant tumor.
Science. 197:893–895. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dexter DL, Kowalski HM, Blazar BA, Fligiel
Z, Vogel R and Heppner GH: Heterogeneity of tumor cells from a
single mouse mammary tumor. Cancer Res. 38:3174–3181.
1978.PubMed/NCBI
|
|
10
|
Heppner GH: Tumor heterogeneity. Cancer
Res. 44:2259–2265. 1984.PubMed/NCBI
|
|
11
|
Cooke SL, Temple J, Macarthur S, Zahra MA,
Tan LT, Crawford RA, Ng CK, Jimenez-Linan M, Sala E and Brenton JD:
Intra-tumour genetic heterogeneity and poor chemoradiotherapy
response in cervical cancer. Br J Cancer. 104:361–368. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Navin N, Kendall J, Troge J, Andrews P,
Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, et
al: Tumourevolution inferred by single-cell sequencing. Nature.
472:90–94. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gerlinger M, Rowan AJ, Horswell S, Math M,
Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N,
Stewart A, et al: Intratumor heterogeneity and branched evolution
revealed by multiregion sequencing. N Engl J Med. 366:883–892.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Patel AP, Tirosh I, Trombetta JJ, Shalek
AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT,
Martuza RL, et al: Single-cell RNA-seq highlights intratumoral
heterogeneity in primary glioblastoma. Science. 344:1396–1401.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mroz EA and Rocco JW: MATH, a novel
measure of intratumor genetic heterogeneity, is high in
poor-outcome classes of head and neck squamous cell carcinoma. Oral
Oncol. 49:211–215. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mroz EA, Tward AD, Pickering CR, Myers JN,
Ferris RL and Rocco JW: High intratumor genetic heterogeneity is
related to worse outcome in patients with head and neck squamous
cell carcinoma. Cancer. 119:3034–3042. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mroz EA, Tward AD, Hammon RJ, Ren Y and
Rocco JW: Intra-tumor genetic heterogeneity and mortality in head
and neck cancer: Analysis of data from the cancer genome atlas.
PLoS Med. 12:e10017862015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rocco JW: Mutant allele tumor
heterogeneity (MATH) and head and neck squamous cell carcinoma.
Head Neck Pathol. 9:1–5. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ostrer H: Changing the game with whole
exome sequencing. Clin Genet. 80:101–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chapman MA, Lawrence MS, Keats JJ,
Cibulskis K, Sougnez C, Schinzel AC, Harview CL, Brunet JP, Ahmann
GJ, Adli M, et al: Initial genome sequencing and analysis of
multiple myeloma. Nature. 471:467–472. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Broad Institute TCGA Genome Data Analysis
Center, . Analysis Overview for Lung Adenocarcinoma (Primary solid
tumor cohort). 28–January. 2016Broad Institute of MIT and Harvard;
https://doi.org/10.7908/c18g8k472016
|
|
23
|
Cheng PF, Dummer R and Levesque MP: Data
mining The cancer genome atlas in the era of precision cancer
medicine. Swiss Med Wkly. 145:w141832015.PubMed/NCBI
|
|
24
|
Koboldt DC, Chen K, Wylie T, Larson DE,
McLellan MD, Mardis ER, Weinstock GM, Wilson RK and Ding L:
VarScan: Variant detection in massively parallel sequencing of
individual and pooled samples. Bioinformatics. 25:2283–2285. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yee J, Kwon MS, Park T and Park M: A
modified entropy-based approach for identifying gene-gene
interactions in case-control study. PLoS One. 8:e693212013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shannon CE: The mathematical theory of
communication. 1963. MD Comput. 14:306–317. 1997.PubMed/NCBI
|
|
27
|
Schreiber T: Measuring information
transfer. Phys Rev Lett. 85:461–464. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Uno H, Cai T, Pencina MJ, D'Agostino RB
and Wei LJ: On the C-statistics for evaluating overall adequacy of
risk prediction procedures with censored survival data. Stat Med.
30:1105–1117. 2011.PubMed/NCBI
|
|
29
|
Landau DA, Carter SL, Stojanov P, McKenna
A, Stevenson K, Lawrence MS, Sougnez C, Stewart C, Sivachenko A,
Wang L, et al: Evolution and impact of subclonal mutations in
chronic lymphocytic leukemia. Cell. 152:714–726. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Marquette D, Pichon E, Deschasse G,
Lemaire B, Lemarie E, Diot P and Marchand-Adam S: Lung cancer in
adults: Better prognosis of patients aged 45 and under related to
good condition and lower TNM stage (a comparative and retrospective
study). Presse Med. 41:e250–e256. 2012.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu M, Pan H, Zhang F, Zhang Y, Zhang Y,
Xia H, Zhu J, Fu W and Zhang X: Identification of TNM
stage-specific genes in lung adenocarcinoma by genome-wide
expression profiling. Oncol Lett. 6:763–768. 2013.PubMed/NCBI
|
|
32
|
Liu Y, Wang L, Lin XY, Wang J, Yu JH, Miao
Y and Wang EH: The transcription factor DEC1
(BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in
non-small-cell lung cancer and inhibits the proliferation through
cyclin D1 in A549 and BE1 cells. Tumour Biol. 34:1641–1650. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu KH, Zhang C, Berry GJ, Altman RB, Ré C,
Rubin DL and Snyder M: Predicting non-small cell lung cancer
prognosis by fully automated microscopic pathology image features.
Nat Commun. 7:124742016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Erb CT, Su KW, Soulos PR, Tanoue LT and
Gross CP: Surveillance practice patterns after curative intent
therapy for stage I non-small-cell lung cancer in the medicare
population. Lung Cancer. 99:200–207. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao T, Xu J, Liu L, Bai J, Xu C, Xiao Y,
Li X and Zhang L: Identification of cancer-related lncRNAs through
integrating genome, regulome and transcriptome features.
MolBiosyst. 11:126–136. 2015.
|
|
36
|
Koch L: Cancer genomics: Non-coding
mutations in the driver seat. Nat Rev Genet. 15:574–575. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Piraino SW and Furney SJ: Beyond the
exome: The role of non-coding somatic mutations in cancer. Ann
Oncol. 27:240–248. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tavare S: Data integration in cancer
genomics: Non-coding mutations. Genet Epidemiology. 585:2015.
|
